Erschienen in:
26.09.2020 | Review
Enhanced Recovery after Surgery (ERAS): a Systematic Review of Randomised Controlled Trials (RCTs) in Bariatric Surgery
verfasst von:
Amilcare Parisi, Jacopo Desiderio, Roberto Cirocchi, Stefano Trastulli
Erschienen in:
Obesity Surgery
|
Ausgabe 12/2020
Einloggen, um Zugang zu erhalten
Abstract
Objective
Our aim was to conduct an up-to-date systematic review of randomised controlled trials (RCTs) to determine the benefits and harms of enhanced recovery after surgery (ERAS) programme in bariatric surgery.
Methods
MEDLINE, Embase, PubMed, CINAHL and the Cochrane Library were searched for RCTs on ERAS versus standard care (SC) until April 2020. The primary endpoint was the length of hospital stay (LOS).
Results
Five RCTs included a total of 610 procedures. ERAS adoption is capable of significantly reducing LOS (MD of − 0.51; 95% CI − 0.92 to − 0.10; P = 0.01) and postoperative nausea and vomiting (PONV) (OR 0.42; 95% CI 0.19 to 0.95; P = 0.04). No significant differences in terms of adverse events and readmissions.
Conclusions
The implementation of ERAS in bariatric surgery produces a significant reduction in LOS and PONV.